Search Results - "Pfister, O"

Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation by Arranto, C. A., Burkard, T., Leuppi-Taegtmeyer, A. B., Gerull, S., Passweg, J. R., Pfister, O., Halter, J. P.

“…Cardiovascular risk factors (CVRF) are frequent among long-term survivors after allogeneic hematopoietic cell transplantation (HCT) but prospective data on…”
Get full text

Prognostic impact of systemic inflammatory diseases in elderly patients with congestive heart failure by Burkard, T, Pfister, O, Rickli, H, Follath, F, Hack, D, Zaker, R, Pittl, U, Handschin, R, Pfisterer, M, Brunner-La Rocca, H-P

“…Inflammation is part of the pathophysiology of congestive heart failure (CHF). However, little is known about the impact of the presence of systemic…”
Get full text

Individual dosage of digoxin in patients with heart failure by MUZZARELLI, S, STRICKER, H, PFISTER, O, FOGLIA, P, MOSCHOVITIS, G, MOMBELLI, G, BRUNNER-LA ROCCA, H

“…After the publication of DIG trial, the therapeutic target of serum digoxin concentration (SDC) for the treatment of heart failure (HF) has been lowered…”
Get full text

Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor γ-chain signaling and inhibited by cyclosporin A by CHKLOVSKAIA, Elena, NISSEN, Catherine, LANDMANN, Lukas, RAHNER, Christoph, PFISTER, Otmar, WODNAR-FILIPOWICZ, Aleksandra

“…The flt3 ligand (FL) is a growth and differentiation factor for primitive hematopoietic precursors, dendritic cells, and natural killer cells. Human T…”
Get full text

Long-term outcomes of patients with tachycardia-induced cardiomyopathy by Serban, T, Weidlich, S, Pfister, O, Kuehne, M, Sticherling, C, Badertscher, P

“…Abstract Introduction Tachycardia-induced cardiomyopathy (TCM) is a reversible type of heart failure that occurs after sustained tachyarrhythmia. TCM can occur…”
Get full text

Bright Multimode Entanglement out of a SiN Microring by Bensemhoun, A., D'Auria, V., Melalkia, M., Esposito, G., Desieres, Y., Guerber, S., Wilmart, Q., Roux, K., Olivier, S., Zavatta, A., Gonzalez-Arciniegas, C., Pfister, O., Martin, A., Etesse, J., Labonte, L., Patera, G., Tanzilli, S.

“…We investigate, in continous variable (CV) regime, multimode entanglement between frequency modes out of a SiN micro-resonator working above its oscillation…”
Get full text

Bright tripartite entanglement in triply concurrent parametric oscillation by Bradley, A. S., Olsen, M. K., Pfister, O., Pooser, R. C.

Get full text

Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) by Rickenbacher, Peter, Kaufmann, Beat A., Maeder, Micha T., Bernheim, Alain, Goetschalckx, Kaatje, Pfister, Otmar, Pfisterer, Matthias, Brunner‐La Rocca, Hans‐Peter

“…Aims While the conditions of heart failure (HF) with reduced (HFrEF, LVEF < 40%) and preserved (HFpEF, LVEF ≥ 50%) left ventricular ejection fraction (LVEF)…”
Get full text

Clinical effect of renal dysfunction on diagnostic and prognostic accuracy of B-type Natriuretic Peptide and N-terminal Pro-B-type Natriuretic Peptide for acute heart failure by Wussler, D, Balkin, M, Michou, E, Sabti, Z, Kozhuharov, N, Strebel, I, Nowak, A, Von Eckardstein, A, Pfister, O, Breidthardt, T, Mueller, C

“…Abstract Background Acute heart failure (AHF) continues to have unacceptable high rates of mortality and morbidity. Therefore, accurate and rapid diagnosis of…”
Get full text

Undetected heart failure in tertiary care: prevalence, predictors and outcomes by Rumora, K, Puelacher, C, Pargger, M, Wussler, D, Schaefer, I, Lopez Ayala, P, Durandi, V, Walter, J E, Hure, G, Strebel, I, Glarner, N, Zellweger, M J, Gualandro, D, Pfister, O, Mueller, C

“…Abstract Background Undetected heart failure (HF) seems to be unexpectedly common in primary care. We hypothesized that undetected HF may also be common in…”
Get full text

Sex-specific guideline target value attainment and prognostic value of low-density lipoprotein cholesterol in tertiary care by Rumora, K, Lopez Ayala, P, Schaefer, I, Durandi, V, Walter, J E, Leibfarth, J P, Hure, G, Isayeva, G, Zellweger, M J, Strebel, I, Von Eckardstein, A, Pfister, O, Mueller, C

“…Abstract Background Factors contributing to guideline-target-level-attainment of low-density lipoprotein cholesterol (LDL-C) in countries with high healthcare…”
Get full text

Prognostic value of a disease-specific health-related quality score in acute heart failure by Belkin, M, Wussler, D, Kozhuharov, N, Michou, E, Sabti, Z, Walter, J, Goudev, A, Flores, D, Shresta, S, Menosi Gualandro, D, Pfister, O, Breidthardt, T, Mueller, C

“…Abstract Background Despite the striking therapeutic progress made in the treatment of heart failure (HF), rehospitalization rate and mortality remain a major…”
Get full text

A comprehensive secondary prevention benchmark (2PBM) score identifying differences in secondary prevention care in patients after acute coronary syndrome by Liu, Y, Haegele, M, Frey, S, Strebel, I, Jordan, F, Lange, R, Burkard, T, Clerc, OF, Pfister, O

“…Abstract Funding Acknowledgements Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): Unrestricted grands from AstraZeneca,…”
Get full text

CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation by Pfister, Otmar, Mouquet, Frédéric, Jain, Mohit, Summer, Ross, Helmes, Michiel, Fine, Alan, Colucci, Wilson S, Liao, Ronglih

“…Heart failure remains a leading cause of morbidity and mortality. The cellular mechanism underlying the development of cardiac dysfunction is a decrease in the…”
Get full text

P4746Direct comparison of c-reactive protein, procalcitonin and interleukin-6 in the diagnosis of pneumonia by Wussler, D, Sabti, Z, Kozhuharov, N, Nowak, A, Badertscher, P, Twerenbold, R, Wildi, K, Puelacher, C, Keller, D, Pfister, O, Osswald, S, Reichlin, T, Breidthart, T, Mueller, C

Get full text

5217Long-term effects of iron deficiency in patients with heart failure with or without anemia - the RAID-HF follow-up study by Wienbergen, H, Pfister, O, Hochadel, M, Fach, A, Backhaus, T, Bruder, O, Remppis, B A, Maeder, M T, Von Scheidt, W, Pauschinger, M, Senges, J, Hambrecht, R

Get full text

P1656Incremental value of interleukin-6 and C-reactive protein to the MEESSI acute heart failure risk score by Wussler, D N, Kozhuharov, N, Sabti, Z, Walter, J, Strebel, I, Miro, O, Rossello, X, Martin-Sanchez, F J, Pocock, S, Nowak, A, Twerenbold, R, Flores, D, Pfister, O, Breidthardt, T, Mueller, C

“…Abstract Background The MEESSI-acute heart failure (AHF) risk score has high accuracy in the prediction of 30-day mortality in patients presenting with AHF and…”
Get full text

End-of-life preferences of elderly patients with chronic heart failure by ROCCA, Hans-Peter Brunner-La, RICKENBACHER, Peter, PFISTERER, Matthias E, RICKLI, Hans, MUZZARELLI, Stefano, SCHINDLER, Ruth, MAEDER, Micha T, JEKER, Urs, KIOWSKI, Wolfgang, LEVENTHAL, Marcia E, PFISTER, Otmar, OSSWALD, Stefan

“…Elderly heart failure (HF) patients are assumed to prefer improved quality of life over longevity, but sufficient data are lacking. Therefore, we assessed the…”
Get full text

P4938Cardioverter-defibrillator does not improve survival among patients with dilative cardiomyopathy and reduced LV ejection fraction: Data from real-world registry EVITA-HF - The answer to DANISH by Jilek, C., Pauschinger, M., von Scheidt, W., Frankenstein, L., Pfister, O., Hambrecht, R., Bruder, O., Brachmann, J., Hartmann, A., Strasser, R., Lewalter, T., Hochadel, M., Senges, J.

Get full text

P3437External validation of the MEESSI acute heart failure risk score by Wussler, D, Walter, J, Du Fay Lavallaz, J, Sabti, Z, Kozhuharov, N, Miro, O, Martin-Sanchez, F, Nowak, A, Badertscher, P, Twerenbold, R, Puelacher, C, Keller, D, Pfister, O, Breidthardt, T, Mueller, C

Get full text